Spanish Ebola patient gets experimental drug
MADRID, Spain - Spain says it has imported a U.S.-made experimental drug to treat a Spanish missionary priest who was evacuated from Liberia last week after testing positive for Ebola.
A Health Ministry statement Monday said the ZMapp drug, made by Mapp Biopharmaceutical Inc. of San Diego, was obtained in Geneva this weekend and brought to Madrid to treat Miguel Pajares.
Two Americans diagnosed with Ebola in Liberia recently have been treated with the drug and are said to be improving.
There is no known cure for Ebola and more than 1,000 people have died in the current outbreak in West Africa.
Pajares, 75, was evacuated from Liberia and placed in isolation Thursday in Madrid's Carlos III hospital.
Desktop NewsClick to open Continuous News in a sidebar that updates in real-time.
Dearman's open for business two years after fire
Diocese reports investigation of sexual misconduct involving local priest
'Tambourine Lady' at Southern, LSU football games garnering national attention
College Drive cleanup kicks off massive city-wide beautification project
Innocent bystander killed in gunfire at underground party